Cargando…
Comment on: Is this a 737 Max Moment for Brolucizumab
Autores principales: | Kayath, Marcia, Sauer, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746201/ https://www.ncbi.nlm.nih.gov/pubmed/32948293 http://dx.doi.org/10.1016/j.ajo.2020.06.035 |
Ejemplares similares
-
Is This a 737 Max Moment for Brolucizumab?
por: Rosenfeld, Philip J., et al.
Publicado: (2020) -
The Boeing 737 MAX: Lessons for Engineering Ethics
por: Herkert, Joseph, et al.
Publicado: (2020) -
Gains in the current understanding of managing neovascular AMD with brolucizumab
por: Bodaghi, Bahram, et al.
Publicado: (2023) -
Mcl-1 levels need not be lowered for cells to be sensitized for ABT-263/737-induced apoptosis
por: Yamaguchi, R, et al.
Publicado: (2011) -
Brolucizumab and immunogenicity
por: Sharma, Ashish, et al.
Publicado: (2020)